Is Ryan Specialty Stock a Good Investment?

Ryan Specialty Investment Advice

  RYAN
To provide specific investment advice or recommendations on Ryan Specialty Group stock, we recommend investors consider the following general factors when evaluating Ryan Specialty Group. This will help you to make an informed decision on whether to include Ryan Specialty in one of your diversified portfolios:
  • Examine Ryan Specialty's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
  • Research Ryan Specialty's leadership team and their track record. Good management can help Ryan Specialty navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
  • Consider the overall health of the Insurance Brokers space and any emerging trends that could impact Ryan Specialty's business and its evolving consumer preferences.
  • Compare Ryan Specialty's performance and market position to its competitors. Analyze how Ryan Specialty is positioned in terms of product offerings, innovation, and market share.
  • Check if Ryan Specialty pays a dividend and its dividend yield and payout ratio.
  • Review what financial analysts are saying about Ryan Specialty's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Ryan Specialty Group stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Ryan Specialty Group is a good investment.
 
Sell
 
Buy
Sell
Macroaxis provides unbiased recommendation on Ryan Specialty Group that should be used to complement current analysts and expert consensus on Ryan Specialty Group. Our trade recommendations engine determines the firm's potential to grow exclusively from the perspective of an investors' current risk tolerance and investing horizon. To make sure Ryan Specialty is not overpriced, please check all Ryan Specialty Group fundamentals, including its cash per share, number of employees, and the relationship between the revenue and cash flow from operations . Given that Ryan Specialty Group has a number of shares shorted of 4.5 M, we recommend you to check out Ryan Specialty Group market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your recent risk tolerance and investing horizon.

Market Performance

Very WeakDetails

Volatility

Very steadyDetails

Hype Condition

StaleDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Follows the market closelyDetails

Investor Sentiment

AlarmedDetails

Analyst Consensus

BuyDetails

Financial Strenth (F Score)

PoorDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails

Examine Ryan Specialty Stock

Researching Ryan Specialty's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 15.0% of the company outstanding shares are owned by corporate insiders. The company has Price/Earnings To Growth (PEG) ratio of 2.28. Ryan Specialty Group last dividend was issued on the 12th of November 2024.
To determine if Ryan Specialty is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Ryan Specialty's research are outlined below:
Ryan Specialty Group generated a negative expected return over the last 90 days
Ryan Specialty Group has a poor financial position based on the latest SEC disclosures
Over 88.0% of the company shares are owned by institutional investors
Latest headline from MacroaxisInsider: Disposition of 4900 shares by Nicholas Cortezi of Ryan Specialty at 65.0328 subject to Rule 16b-3

Ryan Specialty Quarterly Liabilities And Stockholders Equity

8.48 Billion

Ryan Specialty uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Ryan Specialty Group. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Ryan Specialty's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
27th of February 2024
Upcoming Quarterly Report
View
2nd of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View
Earnings surprises can significantly impact Ryan Specialty's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Ryan Specialty's investors have experienced.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-08-11
2022-06-300.350.390.0411 
2021-11-11
2021-09-300.180.240.0633 

Ryan Specialty Target Price Consensus

Ryan target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Ryan Specialty's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   14  Buy
Most Ryan analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Ryan stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Ryan Specialty Group, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Ryan Specialty Target Price Projection

Ryan Specialty's current and average target prices are 66.61 and 74.80, respectively. The current price of Ryan Specialty is the price at which Ryan Specialty Group is currently trading. On the other hand, Ryan Specialty's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Ryan Specialty Market Quote on 30th of January 2025

Low Price65.84Odds
High Price67.37Odds

66.61

Target Price

Analyst Consensus On Ryan Specialty Target Price

Low Estimate68.07Odds
High Estimate83.03Odds

74.8027

Historical Lowest Forecast  68.07 Target Price  74.8 Highest Forecast  83.03
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Ryan Specialty Group and the information provided on this page.

Ryan Specialty Analyst Ratings

Ryan Specialty's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Ryan Specialty stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Ryan Specialty's financials, market performance, and future outlook by experienced professionals. Ryan Specialty's historical ratings below, therefore, can serve as a valuable tool for investors.

Know Ryan Specialty's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Ryan Specialty is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ryan Specialty Group backward and forwards among themselves. Ryan Specialty's institutional investor refers to the entity that pools money to purchase Ryan Specialty's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Geode Capital Management, Llc2024-09-30
1.8 M
Barclays Plc2024-09-30
1.6 M
Stephens Inv Mgmt Group Llc2024-09-30
1.6 M
Polar Capital Holdings Plc2024-09-30
1.5 M
Alliancebernstein L.p.2024-09-30
1.5 M
Morgan Stanley - Brokerage Accounts2024-09-30
1.4 M
Eagle Asset Management, Inc.2024-09-30
1.4 M
Sumitomo Mitsui Trust Group Inc2024-09-30
1.2 M
American Century Companies Inc2024-09-30
1.1 M
Vanguard Group Inc2024-09-30
9.4 M
Blackrock Inc2024-09-30
9.3 M
Note, although Ryan Specialty's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Ryan Specialty's market capitalization trends

The company currently falls under 'Large-Cap' category with a current market capitalization of 17.14 B.

Market Cap

3.65 Billion

Ryan Specialty's profitablity analysis

Last ReportedProjected for Next Year
Return On Tangible Assets 0.01  0.01 
Return On Capital Employed 0.09  0.10 
Return On Assets 0.01  0.01 
Return On Equity 0.10  0.12 
The company has Profit Margin (PM) of 0.04 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.18 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.18.
Determining Ryan Specialty's profitability involves analyzing its financial statements and using various financial metrics to determine if Ryan Specialty is a good buy. For example, gross profit margin measures Ryan Specialty's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Ryan Specialty's profitability and make more informed investment decisions.

Evaluate Ryan Specialty's management efficiency

Ryan Specialty Group has return on total asset (ROA) of 0.0399 % which means that it generated a profit of $0.0399 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2407 %, meaning that it created $0.2407 on every $100 dollars invested by stockholders. Ryan Specialty's management efficiency ratios could be used to measure how well Ryan Specialty manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Ryan Specialty's Return On Capital Employed is very stable compared to the past year. As of the 30th of January 2025, Return On Equity is likely to grow to 0.12, while Return On Tangible Assets are likely to drop 0.01. At this time, Ryan Specialty's Net Tangible Assets are very stable compared to the past year. As of the 30th of January 2025, Non Currrent Assets Other is likely to grow to about 65.7 M, while Total Assets are likely to drop about 5.7 B.
Last ReportedProjected for Next Year
Book Value Per Share 7.71  8.10 
Tangible Book Value Per Share(12.85)(13.49)
Enterprise Value Over EBITDA 14.41  21.43 
Price Book Value Ratio 7.91  5.40 
Enterprise Value Multiple 14.41  21.43 
Price Fair Value 7.91  5.40 
Enterprise Value5.6 B4.7 B
Evaluating the management effectiveness of Ryan Specialty allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The Ryan Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Dividend Yield
0.0067
Forward Dividend Yield
0.0067
Forward Dividend Rate
0.44
Beta
0.621

Basic technical analysis of Ryan Stock

As of the 30th of January, Ryan Specialty holds the Variance of 2.62, risk adjusted performance of (0.03), and Coefficient Of Variation of (2,442). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Ryan Specialty, as well as the relationship between them.

Ryan Specialty's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Ryan Specialty insiders, such as employees or executives, is commonly permitted as long as it does not rely on Ryan Specialty's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Ryan Specialty insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Nicholas Cortezi 2 days ago
Disposition of 4900 shares by Nicholas Cortezi of Ryan Specialty at 65.0328 subject to Rule 16b-3
 
Nicholas Cortezi 3 days ago
Disposition of 4900 shares by Nicholas Cortezi of Ryan Specialty at 65.0228 subject to Rule 16b-3
 
Nicholas Cortezi six days ago
Disposition of 4900 shares by Nicholas Cortezi of Ryan Specialty at 65.1273 subject to Rule 16b-3
 
Nicholas Cortezi over a week ago
Disposition of 4900 shares by Nicholas Cortezi of Ryan Specialty at 65.8361 subject to Rule 16b-3
 
Nicholas Cortezi over a week ago
Disposition of 4900 shares by Nicholas Cortezi of Ryan Specialty at 67.0052 subject to Rule 16b-3
 
Nicholas Cortezi over two weeks ago
Disposition of 4900 shares by Nicholas Cortezi of Ryan Specialty at 66.2564 subject to Rule 16b-3
 
Nicholas Cortezi over three weeks ago
Disposition of 5068 shares by Nicholas Cortezi of Ryan Specialty at 65.1455 subject to Rule 16b-3
 
Nicholas Cortezi over a month ago
Disposition of tradable shares by Nicholas Cortezi of Ryan Specialty at 65.0 subject to Rule 16b-3
 
Mark Katz over a month ago
Disposition of 15000 shares by Mark Katz of Ryan Specialty at 67.3222 subject to Rule 16b-3
 
Patrick Ryan over two months ago
Acquisition by Patrick Ryan of 150 shares of Ryan Specialty at 69.24 subject to Rule 16b-3
 
Jeremiah Bickham over three months ago
Disposition of 1832 shares by Jeremiah Bickham of Ryan Specialty subject to Rule 16b-3
 
Nicholas Cortezi over three months ago
Disposition of 2685 shares by Nicholas Cortezi of Ryan Specialty at 64.5542 subject to Rule 16b-3

Ryan Specialty's Outstanding Corporate Bonds

Ryan Specialty issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Ryan Specialty Group uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Ryan bonds can be classified according to their maturity, which is the date when Ryan Specialty Group has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Understand Ryan Specialty's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Ryan Specialty's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

Consider Ryan Specialty's intraday indicators

Ryan Specialty intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Ryan Specialty stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Ryan Specialty Corporate Filings

F4
28th of January 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
9th of December 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13A
13th of November 2024
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify
10Q
31st of October 2024
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify
Ryan Specialty time-series forecasting models is one of many Ryan Specialty's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Ryan Specialty's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Ryan Stock media impact

Far too much social signal, news, headlines, and media speculation about Ryan Specialty that are available to investors today. That information is available publicly through Ryan media outlets and privately through word of mouth or via Ryan internal channels. However, regardless of the origin, that massive amount of Ryan data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ryan Specialty news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ryan Specialty relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ryan Specialty's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ryan Specialty alpha.

Ryan Specialty Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Ryan Specialty can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Ryan Specialty Group Historical Investor Sentiment

Investor biases related to Ryan Specialty's public news can be used to forecast risks associated with an investment in Ryan. The trend in average sentiment can be used to explain how an investor holding Ryan can time the market purely based on public headlines and social activities around Ryan Specialty Group. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Ryan Specialty's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ryan Specialty and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Ryan Specialty news discussions. The higher the estimate score, the more favorable the investor's outlook on Ryan Specialty.

Ryan Specialty Maximum Pain Price Across April 17th 2025 Option Contracts

Ryan Specialty's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Ryan Specialty close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Ryan Specialty's options.

Ryan Specialty Corporate Management

Mark EsqGeneral VPProfile
Alice ToppingChief OfficerProfile
Brendan MulshineExecutive Vice President Chief Revenue OfficerProfile
Kirk BehrensTechnology OperationsProfile
When determining whether Ryan Specialty Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ryan Specialty's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ryan Specialty Group Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ryan Specialty Group Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ryan Specialty Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Insurance Brokers space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ryan Specialty. If investors know Ryan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ryan Specialty listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.408
Dividend Share
0.33
Earnings Share
0.77
Revenue Per Share
19.549
Quarterly Revenue Growth
0.207
The market value of Ryan Specialty Group is measured differently than its book value, which is the value of Ryan that is recorded on the company's balance sheet. Investors also form their own opinion of Ryan Specialty's value that differs from its market value or its book value, called intrinsic value, which is Ryan Specialty's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ryan Specialty's market value can be influenced by many factors that don't directly affect Ryan Specialty's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Ryan Specialty's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Ryan Specialty is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ryan Specialty's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.